5-((3,5-dichloropyridin-4-yl)thio)-N-(3-((2-morpholinoethyl)amino)-1,1-dioxido-2,3-dihydrobenzo[b]thiophen-6-yl)-1,3,4-thiadiazole-2-carboxamide

ID: ALA5272413

Chembl Id: CHEMBL5272413

Max Phase: Preclinical

Molecular Formula: C22H22Cl2N6O4S3

Molecular Weight: 601.56

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc2c(c1)S(=O)(=O)CC2NCCN1CCOCC1)c1nnc(Sc2c(Cl)cncc2Cl)s1

Standard InChI:  InChI=1S/C22H22Cl2N6O4S3/c23-15-10-25-11-16(24)19(15)35-22-29-28-21(36-22)20(31)27-13-1-2-14-17(12-37(32,33)18(14)9-13)26-3-4-30-5-7-34-8-6-30/h1-2,9-11,17,26H,3-8,12H2,(H,27,31)

Standard InChI Key:  XKLRJJQWMPGZEG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5272413

    ---

Associated Targets(Human)

USP7 Tchem Ubiquitin carboxyl-terminal hydrolase 7 (837 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 601.56Molecular Weight (Monoisotopic): 600.0242AlogP: 3.39#Rotatable Bonds: 8
Polar Surface Area: 126.41Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.09CX Basic pKa: 6.87CX LogP: 2.32CX LogD: 2.21
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.40Np Likeness Score: -1.83

References

1. Li P, Liu HM..  (2020)  Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.,  191  [PMID:32092586] [10.1016/j.ejmech.2020.112107]

Source